CTRV - 1.12 Pre-market now at 1.56/1.59. CMX157 Demonstrates 99% Viral Load Reduction in Ongoing Head-to-Head Phase 2a Clinical Study Vs. Viread® in Hepatitis B Patients http://stockcharts.com/c-sc/sc?s=CTRV&p=D&b=5&g=0&i=t99831041262&r=1476359075669 http://stockcharts.com/c-sc/sc?s=CTRV&p=W&b=5&g=0&i=t42541783242&r=1476359089150